Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 30 September 2019

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 65 Renminbi (CNY) 14 Euro (EUR) 10 Indian rupee (INR) 4 Other currencies (CAD, DKK, GBP, HDK, SEK) 4 Swiss franc (CHF) 3 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public companies 42 Private companies 35 Cash and cash equivalents 11 Funds 10 Other assets 2 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Products on the market 27 Phase III 35 Phase II 15 Phase I 1 Preclinical 1 Profitable 21 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 33 Oncology 18 Orphan diseases 13 Central nervous system 13 Immunology/Inflammation 9 Medical technology / diagnostics 5 Metabolic diseases 4 Digital Health 4 Infectious diseases 2 #AD2D3C #B7D4D8 #2E516C #6d7333 #CD8699 #53465e #f2a58f #94743a #cfa400 #3880C0